Company Filing History:
Years Active: 1994-1995
Title: The Innovations of Joel J Friedman
Introduction
Joel J Friedman is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents and carbapenem antibiotics. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Friedman's latest patents include a process for the preparation of anti-ulcer agents and a novel process for preparing benzylformimidates. The first patent describes anti-ulcer agents that feature a methylsulfinyl bridge between a substituted pyridine moiety and a substituted benzimidazole moiety. This process involves oxidizing the corresponding compounds with magnesium monoperoxyphthalate in a suitable solvent, allowing the product to crystallize and be isolated by filtration. The second patent focuses on a method for producing benzylformimidates, which are essential in the production of certain carbapenem antibiotics. This innovative process ensures a high-yield and high-purity product.
Career Highlights
Joel J Friedman is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Friedman has collaborated with esteemed colleagues such as Robert S Hoerrner and Joseph S Amato. Their combined expertise has further advanced the projects they have undertaken together.
Conclusion
In summary, Joel J Friedman is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in medical treatments. His patents reflect his commitment to innovation and improving healthcare outcomes.